Health equity for older adults with cancer
RD Tucker-Seeley, SF Wallington, B Canin… - Journal of Clinical …, 2021 - ascopubs.org
The number of adults age 65 and older in the United States is expected to increase from
approximately 52 million in 2018 to 95 million in 2060, 1 with women representing …
approximately 52 million in 2018 to 95 million in 2060, 1 with women representing …
Mapping the function of MicroRNAs as a critical regulator of tumor-immune cell communication in breast cancer and potential treatment strategies
AS Abdul Manap, AA Wisham, FW Wong… - Frontiers in Cell and …, 2024 - frontiersin.org
Among women, breast cancer ranks as the most prevalent form of cancer, and the presence
of metastases significantly reduces prognosis and diminishes overall survival rates. Gaining …
of metastases significantly reduces prognosis and diminishes overall survival rates. Gaining …
Trends in surgical axillary management in early stage breast cancer in elderly women: continued over-treatment
RJ Louie, CE Gaber, PD Strassle, KK Gallagher… - Annals of surgical …, 2020 - Springer
Introduction In the past two decades, three prospective randomized trials demonstrated that
elderly women with early stage hormone positive breast cancer had equivalent disease …
elderly women with early stage hormone positive breast cancer had equivalent disease …
[HTML][HTML] Anlotinib inhibits the proliferation, migration and invasion, and induces apoptosis of breast cancer cells by downregulating TFAP2C
F Fang, Q Yuan - Oncology Letters, 2022 - spandidos-publications.com
The vascular endothelial growth factor receptor (VEGFR) network contributes to breast
cancer pathogenesis and progression. Anlotinib is a highly potent multi‑target tyrosine …
cancer pathogenesis and progression. Anlotinib is a highly potent multi‑target tyrosine …
Survival among patients with untreated metastatic breast cancer: “What if I do nothing?”
JK Plichta, SM Thomas, X Wang, SGR McDuff… - Breast Cancer Research …, 2024 - Springer
Purpose We sought to assess survival outcomes of patients with de novo metastatic breast
cancer (dnMBC) who did not receive treatment irrespective of the reason. Methods Adults …
cancer (dnMBC) who did not receive treatment irrespective of the reason. Methods Adults …
[HTML][HTML] Clinicopathologic features, genomic profiles and outcomes of younger vs. older Chinese hormone receptor-positive (HR+)/HER2-negative (HER2-) metastatic …
J Wang, Y Liu, Y Liang, Y Zhang, H Dong… - Frontiers in …, 2023 - frontiersin.org
Background. Poor outcomes have been widely reported for younger vs. older breast cancer
patients, but whether this is due to age itself or the enrichment of aggressive clinical features …
patients, but whether this is due to age itself or the enrichment of aggressive clinical features …
[HTML][HTML] Identification of age differences in cancer-related symptoms in women undergoing chemotherapy for breast cancer in China
T Cai, T Zhou, J Chen, Q Huang, C Yuan, F Wu - BMC Women's Health, 2023 - Springer
Background Both contextual and cancer-related factors could be identified as causes of the
interindividual variability observed for symptoms experienced during breast cancer …
interindividual variability observed for symptoms experienced during breast cancer …
Comparisons of breast conserving therapy versus mastectomy in young and old women with early-stage breast cancer: long-term results using propensity score …
L Wang, Y He, J Li, T Wang, Y Xie, Z Fan… - Breast Cancer Research …, 2020 - Springer
Purpose This study aimed to compare the effect of BCT versus mastectomy on the
recurrence and survival of different-aged patients, and to investigate whether effects of BCT …
recurrence and survival of different-aged patients, and to investigate whether effects of BCT …
Unmet Social Needs and Breast Cancer Screening Utilization and Stage at Presentation
Importance Unmet social needs in local populations may hinder the development of targeted
cancer control interventions aimed at improving screening utilization and early-stage breast …
cancer control interventions aimed at improving screening utilization and early-stage breast …
Neoadjuvant chemotherapy for breast cancer in the elderly: are we accomplishing our treatment goals?
AD Williams, CT Dang, V Sevilimedu, M Morrow… - Annals of surgical …, 2022 - Springer
Introduction Rates of downstaging and tolerability to NAC in women age≥ 70 years with
operable breast cancer have not been well studied. We sought to compare downstaging …
operable breast cancer have not been well studied. We sought to compare downstaging …